Clarksville, TN Online: News, Opinion, Arts & Entertainment.


Topic: Non-valvular Atrial Fibrillation

FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation

 

Washington, D.C.U.S. Food and Drug Administration - FDAThe U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.

Atrial fibrillation, one of the most common types of abnormal heart rhythm, is an abnormal, irregular, and rapid beating of the heart in which the heart’s two upper chambers (atria) do not contract properly, allowing blood clots to form in them. These clots can break off and travel to the brain or other parts of the body.  «Read the rest of this article»

Sections: News | No Comments
 



  • Visit Us On FacebookVisit Us On TwitterVisit Us On GooglePlusVisit Us On PinterestVisit Us On YoutubeCheck Our Feed
  • Personal Controls

    Archives

      December 2016
      S M T W T F S
      « Nov    
       123
      45678910
      11121314151617
      18192021222324
      25262728293031